INTERLEUKIN GENETICS INC: 10-Q filed 2015-05-14

Name: INTERLEUKIN GENETICS INC: 10-Q filed 2015-05-14
Creator: INTERLEUKIN GENETICS INC

What INTERLEUKIN GENETICS INC reported in its quarterly report filed 2015-05-14 (fiscal Q1 2015): 32 published measures, 68 facts as tagged in accession 0001144204-15-030858.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-05-14
Fiscal period: fiscal Q1 2015
Accession: 0001144204-15-030858 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTERLEUKIN GENETICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-03-31	11,486,373	USD
At 2014-12-31	13,267,121	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-03-31	8,665,020	USD
At 2014-12-31	8,750,264	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-03-31	2,821,353	USD
At 2014-12-31	4,516,857	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-03-31	9,643,767	USD
At 2014-12-31	11,466,807	USD
At 2014-03-31	5,713,977	USD
At 2013-12-31	7,542,281	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-1,843,195	USD	90
2014-01-01 to 2014-12-31	6,300,000	USD	365
2014-01-01 to 2014-03-31	-1,664,519	USD	90
2013-01-01 to 2013-12-31	7,100,000	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	16,928	USD	90
2014-01-01 to 2014-03-31	42,724	USD	90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	403,212	USD	90
2014-01-01 to 2014-03-31	487,566	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-03-31	-122,933,507	USD
At 2014-12-31	-121,090,312	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	0	USD	90
2014-01-01 to 2014-03-31	0	USD	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-03-31	739,917	USD
At 2014-12-31	773,779	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	146,310	USD	90
2014-01-01 to 2014-03-31	122,220	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-1,692,564	USD	90
2014-01-01 to 2014-03-31	-1,666,512	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-03-31	10,459,114	USD
At 2014-12-31	12,180,658	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	150,853	USD	90
2014-01-01 to 2014-03-31	0	USD	90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-03-31	3,908,980	USD
At 2014-12-31	4,011,650	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-03-31	646,005	USD
At 2014-12-31	513,927	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-03-31	12,679	USD
At 2014-12-31	14,013	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	1,764,735	USD	90
2014-01-01 to 2014-03-31	1,759,307	USD	90

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-03-31	143,298	USD
At 2014-12-31	171,575	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	72,171	USD	90
2014-01-01 to 2014-03-31	92,795	USD	90

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	331,041	USD	90
2014-01-01 to 2014-03-31	394,771	USD	90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	1,562,791	USD	90
2014-01-01 to 2014-03-31	1,526,606	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	182,530	USD	90
2014-01-01 to 2014-03-31	209,176	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-03-31	172,738,162	shares
At 2014-12-31	172,683,342	shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-03-31	176,351	USD
At 2014-12-31	195,765	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-03-31	110,991	USD
At 2014-12-31	116,919	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-03-31	197,719	USD
At 2014-12-31	343,225	USD

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	19,414	USD	90
2014-01-01 to 2014-03-31	23,525	USD	90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-150,631	USD	90
2014-01-01 to 2014-03-31	1,993	USD	90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-1,334	USD	90
2014-01-01 to 2014-03-31	8,497	USD	90

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-28,277	USD	90
2014-01-01 to 2014-03-31	17,343	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	132,078	USD	90
2014-01-01 to 2014-03-31	-462,284	USD	90

Inspect the source

Entity: INTERLEUKIN GENETICS INC / CIK 0001037649
Captured: 2026-09-22 19:37 UTC
SEC response SHA-256: a1dec64965ae0507fde1f8bdab94feeb924a2817b4582e8fe10de362809c5bbd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001037649.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))